Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 415

1.

Changes in U.S. health care provider attitudes related to contraceptive safety before and after the release of National Guidance.

Zapata LB, Morgan IA, Curtis KM, Folger SG, Whiteman MK.

Contraception. 2019 Jul 29. pii: S0010-7824(19)30370-1. doi: 10.1016/j.contraception.2019.07.142. [Epub ahead of print]

PMID:
31369735
2.

Supplementing preservation solution with mitochondria-targeted H2 S donor AP39 protects cardiac grafts from prolonged cold ischemia reperfusion injury in heart transplantation.

Zhu C, Su Y, Juriasingani S, Zheng H, Veramkovich V, Jiang J, Sener A, Whiteman M, Lacefield J, Nagpal D, Alotaibi F, Liu K, Zheng X.

Am J Transplant. 2019 Jul 23. doi: 10.1111/ajt.15539. [Epub ahead of print]

PMID:
31338943
3.

Healthcare provider knowledge regarding oral contraception effectiveness for women with a history of bariatric malabsorptive procedures.

Shah JP, Jatlaoui TC, Zapata LB, Curtis KM, Pagano HP, Whiteman MK.

Surg Obes Relat Dis. 2019 Jun 17. pii: S1550-7289(19)30280-1. doi: 10.1016/j.soard.2019.06.007. [Epub ahead of print]

PMID:
31311756
4.

Equations to Support Redox Experimentation.

Hancock JT, Whiteman M.

Methods Mol Biol. 2019;1990:183-195. doi: 10.1007/978-1-4939-9463-2_15.

PMID:
31148072
5.

Investigating ROS, RNS, and H2S-Sensitive Signaling Proteins.

Williams E, Whiteman M, Wood ME, Wilson ID, Ladomery MR, Allainguillaume J, Teklic T, Lisjak M, Hancock JT.

Methods Mol Biol. 2019;1990:27-42. doi: 10.1007/978-1-4939-9463-2_3.

PMID:
31148060
6.

Condom Use With Long-Acting Reversible Contraception vs Non-Long-Acting Reversible Contraception Hormonal Methods Among Postpartum Adolescents.

Kortsmit K, Williams L, Pazol K, Smith RA, Whiteman M, Barfield W, Koumans E, Kourtis A, Harrison L, Bauman B, Warner L.

JAMA Pediatr. 2019 Jul 1;173(7):663-670. doi: 10.1001/jamapediatrics.2019.1136.

PMID:
31107513
7.

Hydrogen sulfide inhibits calcification of heart valves; implications for calcific aortic valve disease.

Sikura KÉ, Potor L, Szerafin T, Oros M, Nagy P, Méhes G, Hendrik Z, Zarjou A, Agarwal A, Posta N, Torregrossa R, Whiteman M, Fürtös I, Balla G, Balla J.

Br J Pharmacol. 2019 Apr 24. doi: 10.1111/bph.14691. [Epub ahead of print]

PMID:
31017307
8.

Factors associated with postpartum use of long-acting reversible contraception.

Oduyebo T, Zapata LB, Boutot ME, Tepper NK, Curtis KM, D'Angelo DV, Marchbanks PA, Whiteman MK.

Am J Obstet Gynecol. 2019 Jul;221(1):43.e1-43.e11. doi: 10.1016/j.ajog.2019.03.005. Epub 2019 Mar 15.

PMID:
30885772
9.

In Reply.

Jatlaoui TC, Whiteman MK, Jeng G, Tepper NK, Curtis KM.

Obstet Gynecol. 2019 Mar;133(3):582-583. doi: 10.1097/AOG.0000000000003145. No abstract available.

PMID:
30801457
10.

Factors associated with provision of depot medroxyprogesterone acetate to adolescents by US health care providers.

Ermias Y, Morgan IA, Curtis KM, Whiteman MK, Horton LG, Zapata LB.

Contraception. 2019 May;99(5):300-305. doi: 10.1016/j.contraception.2019.01.005. Epub 2019 Feb 11.

PMID:
30763582
11.

Venous Thromboembolism Among Women Initiating Depot Medroxyprogesterone Acetate Immediately Postpartum.

Tepper NK, Jeng G, Curtis KM, Boutot ME, Boulet SL, Whiteman MK.

Obstet Gynecol. 2019 Mar;133(3):533-540. doi: 10.1097/AOG.0000000000003135.

PMID:
30741807
12.

Health Care Provider Attitudes about the Safety of "Quick Start" Initiation of Long-Acting Reversible Contraception for Adolescents.

Morgan IA, Zapata LB, Curtis KM, Whiteman MK.

J Pediatr Adolesc Gynecol. 2019 Feb 4. pii: S1083-3188(19)30007-5. doi: 10.1016/j.jpag.2019.01.007. [Epub ahead of print]

PMID:
30731216
13.

Abortion Surveillance - United States, 2015.

Jatlaoui TC, Boutot ME, Mandel MG, Whiteman MK, Ti A, Petersen E, Pazol K.

MMWR Surveill Summ. 2018 Nov 23;67(13):1-45. doi: 10.15585/mmwr.ss6713a1.

14.

H2S supplementation: A novel method for successful organ preservation at subnormothermic temperatures.

Juriasingani S, Akbari M, Chan JY, Whiteman M, Sener A.

Nitric Oxide. 2018 Dec 1;81:57-66. doi: 10.1016/j.niox.2018.10.004. Epub 2018 Oct 25.

PMID:
30393129
15.

Health Care Provider Attitudes and Practices Related to 'Quick Start' Provision of Combined Hormonal Contraception and Depot Medroxyprogesterone Acetate to Adolescents.

Morgan IA, Ermias Y, Zapata LB, Curtis KM, Whiteman MK.

J Adolesc Health. 2019 Feb;64(2):211-218. doi: 10.1016/j.jadohealth.2018.08.012. Epub 2018 Nov 2.

PMID:
30392865
16.

Virus Reduction Neutralization Test: A Single-Cell Imaging High-Throughput Virus Neutralization Assay for Dengue.

Whiteman MC, Bogardus L, Giacone DG, Rubinstein LJ, Antonello JM, Sun D, Daijogo S, Gurney KB.

Am J Trop Med Hyg. 2018 Dec;99(6):1430-1439. doi: 10.4269/ajtmh.17-0948.

17.

Interaction of the hydrogen sulfide system with the oxytocin system in the injured mouse heart.

Merz T, Lukaschewski B, Wigger D, Rupprecht A, Wepler M, Gröger M, Hartmann C, Whiteman M, Szabo C, Wang R, Waller C, Radermacher P, McCook O.

Intensive Care Med Exp. 2018 Oct 19;6(1):41. doi: 10.1186/s40635-018-0207-0.

18.

Intrauterine Device Expulsion After Postpartum Placement: A Systematic Review and Meta-analysis.

Jatlaoui TC, Whiteman MK, Jeng G, Tepper NK, Berry-Bibee E, Jamieson DJ, Marchbanks PA, Curtis KM.

Obstet Gynecol. 2018 Oct;132(4):895-905. doi: 10.1097/AOG.0000000000002822.

PMID:
30204688
19.

Mitochondria-targeted hydrogen sulfide attenuates endothelial senescence by selective induction of splicing factors HNRNPD and SRSF2.

Latorre E, Torregrossa R, Wood ME, Whiteman M, Harries LW.

Aging (Albany NY). 2018 Jul 19;10(7):1666-1681. doi: 10.18632/aging.101500.

20.

Cytochrome c Reduction by H2S Potentiates Sulfide Signaling.

Vitvitsky V, Miljkovic JL, Bostelaar T, Adhikari B, Yadav PK, Steiger AK, Torregrossa R, Pluth MD, Whiteman M, Banerjee R, Filipovic MR.

ACS Chem Biol. 2018 Aug 17;13(8):2300-2307. doi: 10.1021/acschembio.8b00463. Epub 2018 Jul 18.

21.

The Mitochondria-Targeted H2S-Donor AP39 in a Murine Model of Combined Hemorrhagic Shock and Blunt Chest Trauma.

Wepler M, Merz T, Wachter U, Vogt J, Calzia E, Scheuerle A, Möller P, Gröger M, Kress S, Fink M, Lukaschewski B, Rumm G, Stahl B, Georgieff M, Huber-Lang M, Torregrossa R, Whiteman M, McCook O, Radermacher P, Hartmann C.

Shock. 2019 Aug;52(2):230-239. doi: 10.1097/SHK.0000000000001210.

PMID:
29927788
22.

Oxidative stress in autoimmune rheumatic diseases.

Smallwood MJ, Nissim A, Knight AR, Whiteman M, Haigh R, Winyard PG.

Free Radic Biol Med. 2018 Sep;125:3-14. doi: 10.1016/j.freeradbiomed.2018.05.086. Epub 2018 May 30. Review.

PMID:
29859343
23.

A Review of Hydrogen Sulfide Synthesis, Metabolism, and Measurement: Is Modulation of Hydrogen Sulfide a Novel Therapeutic for Cancer?

Cao X, Ding L, Xie ZZ, Yang Y, Whiteman M, Moore PK, Bian JS.

Antioxid Redox Signal. 2019 Jul 1;31(1):1-38. doi: 10.1089/ars.2017.7058. Epub 2018 Jun 29.

24.

Dissemination and use of WHO family planning guidance and tools: a qualitative assessment.

Kraft JM, Oduyebo T, Jatlaoui TC, Curtis KM, Whiteman MK, Zapata LB, Gaffield ME.

Health Res Policy Syst. 2018 May 22;16(1):42. doi: 10.1186/s12961-018-0321-1.

25.

Hormonal Contraceptive Use Among Women of Older Reproductive Age: Considering Risks and Benefits.

Tepper NK, Godfrey EM, Folger SG, Whiteman MK, Marchbanks PA, Curtis KM.

J Womens Health (Larchmt). 2018 Apr;27(4):413-417. doi: 10.1089/jwh.2018.6985. Epub 2018 Mar 19.

PMID:
29634450
26.

Hydrogen Sulfide Abrogates Hemoglobin-Lipid Interaction in Atherosclerotic Lesion.

Potor L, Nagy P, Méhes G, Hendrik Z, Jeney V, Pethő D, Vasas A, Pálinkás Z, Balogh E, Gyetvai Á, Whiteman M, Torregrossa R, Wood ME, Olvasztó S, Nagy P, Balla G, Balla J.

Oxid Med Cell Longev. 2018 Jan 21;2018:3812568. doi: 10.1155/2018/3812568. eCollection 2018.

27.

Daily therapy with a slow-releasing H2S donor GYY4137 enables early functional recovery and ameliorates renal injury associated with urinary obstruction.

Lin S, Lian D, Liu W, Haig A, Lobb I, Hijazi A, Razvi H, Burton J, Whiteman M, Sener A.

Nitric Oxide. 2018 Jun 1;76:16-28. doi: 10.1016/j.niox.2018.03.002. Epub 2018 Mar 6.

PMID:
29522906
28.

Renal Protective Effect of Hydrogen Sulfide in Cisplatin-Induced Nephrotoxicity.

Cao X, Xiong S, Zhou Y, Wu Z, Ding L, Zhu Y, Wood ME, Whiteman M, Moore PK, Bian JS.

Antioxid Redox Signal. 2018 Aug 10;29(5):455-470. doi: 10.1089/ars.2017.7157. Epub 2018 Feb 21.

PMID:
29316804
29.

Application of a tablet film coating model to define a process-imposed transition boundary for robust film coating.

van den Ban S, Pitt KG, Whiteman M.

Pharm Dev Technol. 2018 Feb;23(2):176-182. doi: 10.1080/10837450.2017.1384492. Epub 2017 Oct 13.

PMID:
28945146
30.

Update to CDC's U.S. Medical Eligibility Criteria for Contraceptive Use, 2016: Revised Recommendations for the Use of Hormonal Contraception Among Women at High Risk for HIV Infection.

Tepper NK, Krashin JW, Curtis KM, Cox S, Whiteman MK.

MMWR Morb Mortal Wkly Rep. 2017 Sep 22;66(37):990-994. doi: 10.15585/mmwr.mm6637a6.

31.

Trends in contraceptive use according to HIV status among privately insured women in the United States.

Haddad LB, Monsour M, Tepper NK, Whiteman MK, Kourtis AP, Jamieson DJ.

Am J Obstet Gynecol. 2017 Dec;217(6):676.e1-676.e11. doi: 10.1016/j.ajog.2017.08.006. Epub 2017 Sep 1.

32.

Contraception for women with multiple sclerosis: Guidance for healthcare providers.

Houtchens MK, Zapata LB, Curtis KM, Whiteman MK.

Mult Scler. 2017 May;23(6):757-764. doi: 10.1177/1352458517701314. Epub 2017 Mar 24. Review.

33.

Removing barriers to contraception through use of criteria to assess pregnancy risk.

Tepper NK, Curtis KM, Jatlaoui TC, Whiteman MK.

Contraception. 2017 Apr;95(4):323-325. doi: 10.1016/j.contraception.2017.02.002. Epub 2017 Feb 15. No abstract available.

PMID:
28214517
34.

Proso Millet (Panicum miliaceum L.) and Its Potential for Cultivation in the Pacific Northwest, U.S.: A Review.

Habiyaremye C, Matanguihan JB, D'Alpoim Guedes J, Ganjyal GM, Whiteman MR, Kidwell KK, Murphy KM.

Front Plant Sci. 2017 Jan 9;7:1961. doi: 10.3389/fpls.2016.01961. eCollection 2016. Review.

35.

Metabolic, Cardiac, and Renal Effects of the Slow Hydrogen Sulfide-Releasing Molecule GYY4137 During Resuscitated Septic Shock in Swine with Pre-Existing Coronary Artery Disease.

Nußbaum BL, Vogt J, Wachter U, McCook O, Wepler M, Matallo J, Calzia E, Gröger M, Georgieff M, Wood ME, Whiteman M, Radermacher P, Hafner S.

Shock. 2017 Aug;48(2):175-184. doi: 10.1097/SHK.0000000000000834.

PMID:
28107215
36.

Use of combined hormonal contraceptives among women with migraines and risk of ischemic stroke.

Champaloux SW, Tepper NK, Monsour M, Curtis KM, Whiteman MK, Marchbanks PA, Jamieson DJ.

Am J Obstet Gynecol. 2017 May;216(5):489.e1-489.e7. doi: 10.1016/j.ajog.2016.12.019. Epub 2016 Dec 26.

PMID:
28034652
37.

Healthcare Provider Attitudes of Safety of Intrauterine Devices in the Postpartum Period.

Rauh-Benoit LA, Tepper NK, Zapata LB, Whiteman MK, Curtis KM, Mandel MG, Marchbanks PA, Jamieson DJ.

J Womens Health (Larchmt). 2017 Jul;26(7):768-773. doi: 10.1089/jwh.2016.5985. Epub 2016 Dec 19.

PMID:
27992305
38.

AP39, a mitochondria-targeting hydrogen sulfide (H2 S) donor, protects against myocardial reperfusion injury independently of salvage kinase signalling.

Karwi QG, Bornbaum J, Boengler K, Torregrossa R, Whiteman M, Wood ME, Schulz R, Baxter GF.

Br J Pharmacol. 2017 Feb;174(4):287-301. doi: 10.1111/bph.13688. Epub 2017 Jan 24.

39.

Updated Guidance for Safe and Effective Use of Contraception.

Tepper NK, Curtis KM, Jatlaoui TC, Whiteman MK.

J Womens Health (Larchmt). 2016 Nov;25(11):1097-1101.

PMID:
27841957
40.

Protective effects of exogenous and endogenous hydrogen sulfide in mast cell-mediated pruritus and cutaneous acute inflammation in mice.

Rodrigues L, Ekundi-Valentim E, Florenzano J, Cerqueira AR, Soares AG, Schmidt TP, Santos KT, Teixeira SA, Ribela MT, Rodrigues SF, de Carvalho MH, De Nucci G, Wood M, Whiteman M, Muscará MN, Costa SK.

Pharmacol Res. 2017 Jan;115:255-266. doi: 10.1016/j.phrs.2016.11.006. Epub 2016 Nov 10.

PMID:
27840098
41.

GYY4137, a Slow-Releasing Hydrogen Sulfide Donor, Ameliorates Renal Damage Associated with Chronic Obstructive Uropathy.

Lin S, Visram F, Liu W, Haig A, Jiang J, Mok A, Lian D, Wood ME, Torregrossa R, Whiteman M, Lobb I, Sener A.

J Urol. 2016 Dec;196(6):1778-1787. doi: 10.1016/j.juro.2016.05.029. Epub 2016 May 10.

PMID:
27177428
42.

Hydrogen sulfide donors alleviate itch secondary to the activation of type-2 protease activated receptors (PAR-2) in mice.

Coavoy-Sánchez SA, Rodrigues L, Teixeira SA, Soares AG, Torregrossa R, Wood ME, Whiteman M, Costa SKP, Muscará MN.

Pharmacol Res. 2016 Nov;113(Pt A):686-694. doi: 10.1016/j.phrs.2016.09.030. Epub 2016 Oct 6.

43.

The novel mitochondria-targeted hydrogen sulfide (H2S) donors AP123 and AP39 protect against hyperglycemic injury in microvascular endothelial cells in vitro.

Gerő D, Torregrossa R, Perry A, Waters A, Le-Trionnaire S, Whatmore JL, Wood M, Whiteman M.

Pharmacol Res. 2016 Nov;113(Pt A):186-198. doi: 10.1016/j.phrs.2016.08.019. Epub 2016 Aug 23.

44.

Hydrogen Sulfide Protects Renal Grafts Against Prolonged Cold Ischemia-Reperfusion Injury via Specific Mitochondrial Actions.

Lobb I, Jiang J, Lian D, Liu W, Haig A, Saha MN, Torregrossa R, Wood ME, Whiteman M, Sener A.

Am J Transplant. 2017 Feb;17(2):341-352. doi: 10.1111/ajt.14080. Epub 2016 Nov 29.

45.

Removing medical barriers to contraception - evidence-based recommendations from the Centers for Disease Control and Prevention, 2016.

Curtis KM, Tepper NK, Jatlaoui TC, Whiteman MK.

Contraception. 2016 Dec;94(6):579-581. doi: 10.1016/j.contraception.2016.08.007. Epub 2016 Aug 30. No abstract available.

PMID:
27589882
46.

U.S. Selected Practice Recommendations for Contraceptive Use, 2016.

Curtis KM, Jatlaoui TC, Tepper NK, Zapata LB, Horton LG, Jamieson DJ, Whiteman MK.

MMWR Recomm Rep. 2016 Jul 29;65(4):1-66. doi: 10.15585/mmwr.rr6504a1.

PMID:
27467319
47.

U.S. Medical Eligibility Criteria for Contraceptive Use, 2016.

Curtis KM, Tepper NK, Jatlaoui TC, Berry-Bibee E, Horton LG, Zapata LB, Simmons KB, Pagano HP, Jamieson DJ, Whiteman MK.

MMWR Recomm Rep. 2016 Jul 29;65(3):1-103. doi: 10.15585/mmwr.rr6503a1.

PMID:
27467196
48.

Contraceptive use among women with multiple sclerosis: a systematic review.

Zapata LB, Oduyebo T, Whiteman MK, Houtchens MK, Marchbanks PA, Curtis KM.

Contraception. 2016 Dec;94(6):612-620. doi: 10.1016/j.contraception.2016.07.013. Epub 2016 Jul 21. Review.

49.

The safety of intrauterine devices in breastfeeding women: a systematic review.

Berry-Bibee EN, Tepper NK, Jatlaoui TC, Whiteman MK, Jamieson DJ, Curtis KM.

Contraception. 2016 Dec;94(6):725-738. doi: 10.1016/j.contraception.2016.07.006. Epub 2016 Jul 13. Review.

PMID:
27421765
50.

Pharmacological postconditioning against myocardial infarction with a slow-releasing hydrogen sulfide donor, GYY4137.

Karwi QG, Whiteman M, Wood ME, Torregrossa R, Baxter GF.

Pharmacol Res. 2016 Sep;111:442-451. doi: 10.1016/j.phrs.2016.06.028. Epub 2016 Jul 1.

PMID:
27378570

Supplemental Content

Loading ...
Support Center